Drug-Eluting Bioabsorbable Stents Market Share, Segmentation, Report 2024

1
Drug-Eluting Bioabsorbable Stents Market
Global Industry Analysis Report, Share, Growth,
Price Trends and Forecast, 2016 2024 Global
Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
Low Power Wide Area Network
2
Regional Analysis of Drug-Eluting Bioabsorbable
Stents Market

• Europe dominates the drug eluting bioabsorbable
  stents market followed by North America.
  Increasing aged population, established
  healthcare infrastructure, and rising awareness
  among patients for these devices in developed
  countries, such as Germany, the UK, and France,
  will accelerate the market size.
• U.S. drug eluting bioabsorbable stents market
  will witness a significant growth over the coming
  years. Increasing prevalence of coronary artery
  diseases, sedentary lifestyle, and growing
  elderly population base will fuel the demand for
  drug eluting stents.
• APAC is poised to be the fastest growing drug
  eluting bioabsorbable stents market over the
  forecast timeline. Developing economies, such as
  India, China, and Japan, will witness a
  tremendous growth owing to the increasing elderly
  patient pool, rising prevalence of obesity
  leading to cardiac diseases, and rising
  government initiatives. These factors will fuel
  bioabsorbable stents demand in the future.

3
Application Analysis of Drug-Eluting
Bioabsorbable Stents Market

• Based on the application, the market is
  categorized into coronary artery diseases and
  peripheral artery diseases.
• The coronary segment is leading the market and
  will continue to witness a tremendous growth in
  the future due to the growing elderly patient
  pool, increasing prevalence of obesity,
  escalating number of deaths due to cardiac
  diseases, and increasing coronary interventions
  procedures.
• By end-user, the market is segmented into
  hospitals and cardiac centers. The hospital
  segment dominates the market in terms of revenue
  and will continue to lead in the future.
• This is attributed to established medical
  infrastructure along with highly skilled and
  trained professionals to cater to the needs of
  patients suffering from coronary and peripheral
  artery diseases.

4
Competitive Market Share of Drug-Eluting
Bioabsorbable Stents Market

• Some of the prominent players in this market
  include Medtronic, B.Braun Melsungen, Abbott
  Laboratories, Boston Scientific Corporation,
  Medtronic, Biosensors International, and Terumo
  Corporation. To expand the product portfolio and
  capture higher market share, these players are
  focusing on unique growth strategies such as
  acquisitions, mergers, and new product launches.
• Some of the other notable industry vendors are
  MicroPort Scientific Corporation, Alvimedica,
  Biotronik, Elixir Medical Corporation, and
  Innovative Health Technologies. These players are
  adopting collaborations and geographic expansion
  growth strategies to enhance their manufacturing
  capabilities as well as increasing their presence
  across the globe.

5

Browse Full Market Research Report On
Drug-Eluting Bioabsorbable Stents Market _at_
http//bit.ly/2p09Uqz Request for an
in-depth table of contents for this report _at_
https//www.gminsights.com/request-toc/upcoming/13
83
6
Stay In Touch Website www.gminsights.com Soci
al Media